A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer-Reference-Cited by-同舟云学术

A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer

Published:2022-03 Issue: Volume:165 Page:34-42
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cui Wanyuan,Milner-Watts Charlotte,McVeigh Terri P.,Minchom Anna,Bholse Jaishree,Davidson Michael,Yousaf Nadia,MacMahon Suzanne,Mugalaasi Hood,Gunapala Ranga,Lee Richard,George Angela,Popat Sanjay,O'Brien Mary

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J. Clin. Oncol.,2021

2. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials;Yang;Lancet Oncol.,2015

3. Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations;Yang;J. Clin. Oncol.,2013

4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

5. C.K. Lee, L. Davies, Y.L. Wu, T. Mitsudomi, A. Inoue, R. Rosell, et al. Gefitinib or Erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival. J. Natl. Cancer Inst. 109(6) 2017. doi:10.1093/jnci/djw279.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC);Clinical Oncology;2024-10

2. Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses;Inside Precision Medicine;2024-08-01

3. Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases;The Journal of Liquid Biopsy;2024-06

4. Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family;Lung Cancer;2024-05

5. Leveraging the Full Potential of Sensitive Circulating Tumor DNA Analyses;Inside Precision Medicine;2024-04-01